fda glp-1 compounding crackdown news october 2025 Puts Pressure on Compounders, Telehealth Providers FDA warns against compounded GLP-1

That "is it harming your health" question is the most practical filter for separating an aesthetic goal from a medical one, and for thinking about who might actually need a lifelong medication

20: 16441651 [DOI] [PubMed] [Google Scholar] 130.Ding KH, Shi XM, Zhong Q, et al

According to MHRA product information, constipation is very common (affecting more than 1 in 10 people) with higher doses used for weight management (Wegovy, Saxenda), while it is common (affecting up to 1 in 10 people) with doses typically used for diabetes (Ozempic, Victoza)

The regulation of PFAS, or forever chemicals, continues to intensify with significant developments at both federal and state levels, addressing their environmental and health impacts

1 reason for stopping GLP1s is financial, Hill said